55
Views
19
CrossRef citations to date
0
Altmetric
Original Research

A model combining TNM stage and tumor size shows utility in predicting recurrence among patients with hepatocellular carcinoma after resection

, , , , &
Pages 3707-3715 | Published online: 20 Sep 2018

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Anna Sessa, Sébastien Mulé, Raffaele Brustia, Hélène Regnault, Athena Galletto Pregliasco, Rami Rhaiem, Vincent Leroy, Daniele Sommacale, Alain Luciani, Julien Calderaro & Giuliana Amaddeo. (2022) Macrotrabecular-Massive Hepatocellular Carcinoma: Light and Shadow in Current Knowledge. Journal of Hepatocellular Carcinoma 9, pages 661-670.
Read now

Articles from other publishers (18)

Yangyang Wang, Xu Sun, Cao Chen, Hongbin Ge, Juhui Sun, Enliang Li, Zhixiong Cai, Qihan Fu, Xuqi Sun, Jiangchao Wu, Mao Ye, Wanyue Cao, Qitai Chen, Xiaobao Wei, Xu Han, Ke Sun, Qiang Yan, Wenyong Huang, Linquan Wu, Yongyi Zeng, Qi Zhang & Tingbo Liang. (2024) Optimizing hepatocellular carcinoma disease staging systems by incorporating tumor micronecrosis: A multi-institutional retrospective study. Cancer Letters 585, pages 216654.
Crossref
Li-Yue Sun, Qing Ouyang, Wen-Jian Cen, Fang Wang, Wen-Ting Tang & Jian-Yong Shao. (2021) A Model Based on Artificial Intelligence Algorithm for Monitoring Recurrence of HCC after Hepatectomy. The American Surgeon™ 89:5, pages 1468-1478.
Crossref
Long-Bin Jeng, Tsai-Chung Li, Wen-Ling Chan & Chiao-Fang Teng. (2023) Combination of Hepatitis B Virus Pre-S2 Gene Deletion Mutation and Tumor-Node-Metastasis Stage Predicts Higher Hepatocellular Carcinoma Recurrence after Curative Surgical Resection. Biomedicines 11:3, pages 923.
Crossref
Liu Yang, Long-fei Zeng, Guo-qing Hong, Qing Luo & Xing Lai. (2022) Construction of a Novel Clinical Stage-Related Gene Signature for Predicting Outcome and Immune Response in Hepatocellular Carcinoma. Journal of Immunology Research 2022, pages 1-10.
Crossref
Wencui Li, Lizhu Han, Bohan Xiao, Xubin Li & Zhaoxiang Ye. (2022) A Predictive Nomogram of Early Recurrence for Patients with AFP-Negative Hepatocellular Carcinoma Underwent Curative Resection. Diagnostics 12:5, pages 1073.
Crossref
Li-Yue Sun, Wen-Jian Cen, Wen-Ting Tang, Ling Deng, Fang Wang, Xiao-Meng Ji, Jiao-Jiao Yang, Ren-Jing Zhang, Xu-Hui Zhang & Zi-Ming Du. (2022) Alpha-Fetoprotein Ratio Predicts Alpha-Fetoprotein Positive Hepatocellular Cancer Patient Prognosis after Hepatectomy. Disease Markers 2022, pages 1-9.
Crossref
Guilherme Moura CunhaMojgan HosseiniAlessandro FurlanKathryn J. Fowler. (2022) Hepatocellular Carcinoma Staging: Differences Between Radiologic and Pathologic Systems and Relevance to Patient Selection and Outcomes in Liver Transplantation. American Journal of Roentgenology 218:1, pages 77-86.
Crossref
Xu Tong & Jing Li. (2022) Noninvasively predict the micro-vascular invasion and histopathological grade of hepatocellular carcinoma with CT-derived radiomics. European Journal of Radiology Open 9, pages 100424.
Crossref
Yi Fu, Xindong Wei, Qiuqin Han, Jiamei Le, Yujie Ma, Xinjie Lin, Yuhui Xu, Ning Liu, Xuan Wang, Xiaoni Kong, Jinyang Gu, Ying Tong & Hailong Wu. (2021) Identification and characterization of a 25-lncRNA prognostic signature for early recurrence in hepatocellular carcinoma. BMC Cancer 21:1.
Crossref
Dongdong Zhou, Xiaoli Liu, Xinhui Wang, Fengna Yan, Peng Wang, Huiwen Yan, Yuyong Jiang & Zhiyun Yang. (2021) A prognostic nomogram based on LASSO Cox regression in patients with alpha-fetoprotein-negative hepatocellular carcinoma following non-surgical therapy. BMC Cancer 21:1.
Crossref
Min Deng, Lin Fang, Shao-Hua Li, Rong-Ce Zhao, Jie Mei, Jing-Wen Zou, Wei Wei & Rong-Ping Guo. (2021) Expression pattern and prognostic value of N6-methyladenosine RNA methylation key regulators in hepatocellular carcinoma. Mutagenesis 36:5, pages 369-379.
Crossref
Dongye Yang, Hongliang Wu, Wenxiong Nong, Min Zheng, Angui Li, Yang Wang, Mu Li, Qian Chen, Shengguang Yuan, Junxiong Yu & Weijia Liao. (2021) A new model based on gamma-glutamyl transpeptidase to platelet ratio (GPR) predicts prognostic outcome after curative resection of solitary hepatocellular carcinoma. Clinics and Research in Hepatology and Gastroenterology 45:5, pages 101509.
Crossref
Haohan Liu, Yongcong Yan, Ruibing Chen, Mengdi Zhu, Jianhong Lin, Chuanchao He, Bingchao Shi, Kai Wen, Kai Mao & Zhiyu Xiao. (2020) Integrated nomogram based on five stage-related genes and TNM stage to predict 1-year recurrence in hepatocellular carcinoma. Cancer Cell International 20:1.
Crossref
Yue-Lin Zhang, Chun-Hui Nie, Feng Chen, Tan-Yang Zhou, Guan-Hui Zhou, Tong-Yin Zhu, Sheng-Qun Chen, Xin-Hua Chen, Hong-Liang Wang, Bao-Quan Wang, Zi-Niu Yu, Li Jing, Zhi-Min He & Jun-Hui Sun. (2020) Adjuvant Transarterial Chemoembolization for Barcelona Clinic Liver Cancer Stage A Hepatocellular Carcinoma After Hepatectomy. Frontiers in Oncology 10.
Crossref
Zuojing Yin, Qiming Wang, Xinmiao Yan, Lu Zhang, Kailin Tang, Zhiwei Cao & Tianyi Qiu. (2020) Reveal the Regulation Patterns of Prognosis-Related miRNAs and lncRNAs Across Solid Tumors in the Cancer Genome Atlas. Frontiers in Cell and Developmental Biology 8.
Crossref
Peng Chen, Na Yang, Li Xu, Fangfang Zhao & Min Zhang. (2019) Increased expression of protease-activated receptors 2 indicates poor prognosis in HBV related hepatocellular carcinoma. Infectious Agents and Cancer 14:1.
Crossref
Yejoo Jeon, Mark Benedict, Tamar Taddei, Dhanpat Jain & Xuchen Zhang. (2019) Macrotrabecular Hepatocellular Carcinoma. American Journal of Surgical Pathology 43:7, pages 943-948.
Crossref
Junyu Wu, Cheng Zhang, Yau-Tuen Chan, Yuanjun Lu, Hor-Yue Tan, Yibin Feng & Ning Wang. (2022) Preoperative Immune Cells Infiltration in the Tumor Microenvironment as a Prediction and Prognostic Factor for Postoperative Recurrence in Hepatocellular Carcinoma. SSRN Electronic Journal.
Crossref